These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1119535)

  • 1. Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.
    Huffer WE; Kuzela D; Popovtzer MM
    Am J Pathol; 1975 Mar; 78(3):365-84. PubMed ID: 1119535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic bone disease in chronic renal failure. II. Renal transplant patients.
    Huffer WE; Kuzela D; Popovtzer MM; Starzl TE
    Am J Pathol; 1975 Mar; 78(3):385-400. PubMed ID: 1091152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft tissue calcification in chronic dialysis patients.
    Kuzela DC; Huffer WE; Conger JD; Winter SD; Hammond WS
    Am J Pathol; 1977 Feb; 86(2):403-24. PubMed ID: 836675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction.
    Lafage-Proust MH; Combe C; Barthe N; Aparicio M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):512-9. PubMed ID: 10022409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
    Tsai WC; Peng YS; Yang JY; Hsu SP; Wu HY; Pai MF; Chang JF; Chen HY
    Blood Purif; 2013; 36(2):116-21. PubMed ID: 24217122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis.
    Nilsson P; Melsen F; Malmaeus J; Danielson BG; Mosekilde L
    Bone; 1985; 6(1):21-7. PubMed ID: 2581596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diet, dialysis and transplantation on bone lesions in chronic uraemia.
    Bonomini V; Albertazzi A; Bortolotti GC; Vangelista A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):324-31. PubMed ID: 4606504
    [No Abstract]   [Full Text] [Related]  

  • 10. Metacarpal cortical thickness in uremic patients on regular hemodialysis.
    Del Rio A; Rico H; Carrera F; Torrente J; D'Ocón MT; Espinós D
    Nephron; 1978; 22(4-6):354-60. PubMed ID: 740097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a diphosphonate on uremic hyperparathyroidism.
    Kaye M
    Nephron; 1973; 10(2):188-94. PubMed ID: 4710979
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiological, biochemical and clinical aspects of uremic osteopathy in patients with long term dialysis].
    Frey FJ; Jonutis AJ; Bergstein Z; Hodler J; Flury W
    Schweiz Med Wochenschr; 1976 Oct; 106(42):1438-46. PubMed ID: 1006271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic bone disease and aluminium contamination in 38 uremic patients. A bone histomorphometric study.
    Pødenphant J; Heaf JG; Joffe P
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):1-6. PubMed ID: 3962676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone mineral metabolism in patients with chronic kidney disease on dialysis in Southern Metropolitan Santiago].
    Ruiz de Arechavaleta A; Quintero N; Parra E U D; Jara A; Russo M; Zitko P; Pefaur J
    Rev Med Chil; 2015 Feb; 143(2):168-74. PubMed ID: 25860358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and soft tissue damage in patients with chronic renal failure during treatment by systematic hemodialysis].
    Nenov D; Kolev Z; Vicheva S
    Urol Nefrol (Mosk); 1984; (6):53-6. PubMed ID: 6516077
    [No Abstract]   [Full Text] [Related]  

  • 19. The place of subtotal parathyroidectomy in the management of patients with chronic renal failure.
    Katz AI; Hampers CL; Wilson RE; Bernstein DS; Wachman A; Merrill JP
    Trans Am Soc Artif Intern Organs; 1968; 14():376-84. PubMed ID: 5701560
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.